These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 659557)

  • 1. Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.
    Eksborg S; Ehrsson H; Andersson B; Beran M
    J Chromatogr; 1978 Jun; 153(1):211-8. PubMed ID: 659557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase liquid chromatographic determination of idarubicin and its 13-hydroxy metabolite in human plasma.
    Eksborg S; Nilsson B
    J Chromatogr; 1989 Mar; 488(2):427-34. PubMed ID: 2745632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex.
    Andersson B; Andersson I; Beran M; Ehrsson H; Eksborg S
    Cancer Chemother Pharmacol; 1979; 2(1):15-7. PubMed ID: 498413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol.
    Eksborg S; Ehrsson H; Andersson I
    J Chromatogr; 1979 Dec; 164(4):479-86. PubMed ID: 541423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC determination of daunorubicin and daunorubicinol in human plasma.
    Hulhoven R; Desager JP
    Biomedicine; 1977 Apr; 27(3):102-4. PubMed ID: 890014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy.
    Gessner T; Preisler HD; Azarnia N; Bolanowska W; Vogler WR; Grunwald H; Joyce R; Goldberg J
    Med Oncol Tumor Pharmacother; 1987; 4(1):23-31. PubMed ID: 3600054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis.
    Hempel G; Schulze-Westhoff P; Flege S; Boos J
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):221-8. PubMed ID: 11486832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detection.
    Akpofure C; Riley CA; Sinkule JA; Evans WE
    J Chromatogr; 1982 Nov; 232(2):377-83. PubMed ID: 7153284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.
    Eksborg S
    J Chromatogr; 1978 Feb; 149():225-32. PubMed ID: 649731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.
    Cusack BJ; Young SP; Olson RD
    Cancer Chemother Pharmacol; 1995; 35(3):213-8. PubMed ID: 7805179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis.
    Griese N; Blaschke G; Boos J; Hempel G
    J Chromatogr A; 2002 Dec; 979(1-2):379-88. PubMed ID: 12498269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatographic determination of tetracycline in plasma and urine.
    Eksborg S; Ehrsson H; Lönroth U
    J Chromatogr; 1979 Dec; 185():583-91. PubMed ID: 546934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunorubicin, daunorubicinol and DNA plasma kinetics after I.V. administration of daunorubican-DNA complex in the rabbit.
    Hulhoven R
    Biomedicine; 1978 Jul; 29(5):164-7. PubMed ID: 719130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the accumulation of daunorubicin in human leukemic cells by prolonging the infusion time.
    Paul C; Tidefelt U; Liliemark J; Peterson C
    Leuk Res; 1989; 13(2):191-6. PubMed ID: 2927175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
    Erb N; Erttmann R; Landbeck G
    Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
    Bolanowska W; Gessner T; Preisler H
    Cancer Chemother Pharmacol; 1983; 10(3):187-91. PubMed ID: 6574828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex.
    Andersson B; Beran M
    Cancer Chemother Pharmacol; 1980; 4(3):205-7. PubMed ID: 7397945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemia.
    Paul C; Liliemark J; Tidefelt U; Gahrton G; Peterson C
    Ther Drug Monit; 1989; 11(2):140-8. PubMed ID: 2718219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia.
    Bellott R; Auvrignon A; Leblanc T; Pérel Y; Gandemer V; Bertrand Y; Méchinaud F; Bellenger P; Vernois J; Leverger G; Baruchel A; Robert J
    Cancer Chemother Pharmacol; 2001; 47(1):15-21. PubMed ID: 11221955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol.
    Hempel G; Relling MV; de Rossi G; Stary J; De Lorenzo P; Valsecchi MG; Barisone E; Boos J; Pieters R
    Pediatr Blood Cancer; 2010 Mar; 54(3):355-60. PubMed ID: 19731319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.